Azuca Brings Innovative Artisan Edibles to Medical Market

—New Brand Leverages Breakthrough Technology to Offer Customizable Culinary Cannabis Experience—

NEW YORK (October 2018) — Azuca, a line of all-natural cannabis edibles and ingredients, is launching in the medical-use market, with products hitting shelves in the iAnthus network of dispensaries. Azuca’s product suite will fill the cannabis industry’s demand for an edible that offers a more controllable experience—not to mention a great taste.

The line consists of a variety of cannabis-infused sweeteners and syrups in THC, CBD and combination formulas, which can be added to food and beverages as the building blocks of a sophisticated culinary cannabis experience. Products are available in a wide range of flavors, all made in artisan batches to deliver medical benefits that not only provide patients with discreet relief, but are delicious as well. In addition to the sweeteners—with flavor options including lemon, pomegranate and orange—the line also offers an array of shortbread cookies, chocolate coins and Pâte de Fruit in both high and low doses, customizable for individual medical needs.

Azuca products are set apart by their patent-pending technology, developed by Azuca Founder and Chief Creative Officer Ron Silver, which wraps the cannabis molecules to make them more water soluble, allowing for easy digestion in the stomach, and avoiding the gut and liver where cannabis is degraded and absorption is slowed. Increased water solubility is associated with increased bioavailability and faster onset, enabling patients to more accurately and effectively medicate.

Silver brings a unique set of expertise to the cannabis market, as a renowned chef and owner of Bubby’s, a popular brunch destination with two locations in New York City and seven in Japan. Recognizing a void for trustworthy edibles in the marketplace, Silver developed the underlying technology for Azuca over a two-year period of R&D, before infusing it into specially crafted edibles that combine the science with chef-quality taste to offer medical relief in a safer, more desirable way.

Azuca is licensing its Intellectual Property to iAnthus, to bring its innovative cannabis solutions to iAnthus affiliates like the Massachusetts Registered Medical Dispensary, Mayflower Medicinals. Mayflower Medicinals will cultivate and manufacture world-class cannabis products out of its 36,000 square-foot, state-of-the-art production facility in Holliston, MA.

“Even as cannabis becomes less stigmatized in the U.S., there is still a widespread issue with edibles causing unpredictable and negative experiences. Cannabis is a powerful medicinal plant with a myriad of health benefits that should not be deterred by a lack of trust. To resolve the common problems plaguing today’s consumers, Azuca edibles utilize a unique technology that delivers a more controllable effect. Launching with iAnthus is the first of many milestones for Azuca, as we continue to grow our brand and push the boundaries of product innovation,” said Silver.

Leading the Azuca management team is Kim Sanchez Rael, CEO, who has entered the cannabis industry with over 20 years of entrepreneurial start-up, executive management, policy and venture investing experience.

# # #

About Azuca

Azuca is a privately-held, investor-backed cannabis company which commercializes a line of edible products using patent-pending technology. This technology wraps cannabis molecules in order to make them more water soluble, to increase bioavailability and effectiveness and minimize wait-time for more controlled, reliable edibles.

The Azuca product line consists of sweeteners and syrups which can be added to food and beverages as the building blocks of a sophisticated culinary cannabis experience. CBD products are anticipated to be available nationwide from late 2018, while THC products will be launching through licensed dispensaries in legal cannabis markets.

The Cannabis Market

Azuca is tapping into the burgeoning cannabis market with its edible line. According to industry estimates, the legal cannabis market is expected to grow to $50 billion by 2026. Currently recreational use is legal in nine states plus Washington D.C., while medical marijuana is legal in 30 states, with edibles representing a fast-growing segment.  New adopters are often health conscious and averse to smoking and vaping, making cannabis edibles the ideal solution.

For more information or to schedule an interview, please contact Gabrielle Wesseldyk at gabrielle@rosengrouppr.com or 212.255.0945.